Pharmacy counselling models: A means to improve drug use

Journal of Clinical Pharmacy and Therapeutics

Volumn 35, Issue 4, 2010, Pages 439-451

  Ax, F ^a   Branstad J O ^b   Westerlund, T ^c,d  

^a Apoteket Vita Tigern   (Sweden)

^b Apoteket AB   (Sweden)

^c Apoteket AB   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

community pharmacy; counselling models; DRPs; drug related problems; pharmaceutical care; Sweden

Indexed keywords

AGENTS ACTING ON THE EYE; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; RESPIRATORY TRACT AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; DRUG USE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MODEL; MULTICENTER STUDY; PATIENT COUNSELING; PHARMACEUTICAL CARE; PHARMACIST ATTITUDE; PHARMACY COUNSELLING MODEL; PRESCRIPTION; SINGLE BLIND PROCEDURE; SWEDEN;

COMMUNITY PHARMACY SERVICES; DRUG INFORMATION SERVICES; FOLLOW-UP STUDIES; HUMANS; PATIENT EDUCATION AS TOPIC; PILOT PROJECTS; PRESCRIPTION DRUGS; PROFESSIONAL-PATIENT RELATIONS; QUESTIONNAIRES; SWEDEN;

EID: 77954516056     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2009.01138.x     Document Type: Article

References (50)

1. Jin J, Sklar GE, Min Sen Oh V, Chuen Li S (2008) Factors affecting therapeutic compliance: a review from the patient's perspective. Therapeutics and Clinical Risk Management, 4, 269 286.
2. Westerlund T, Almarsdóttir AB, Melander A (1999) Drug-related problems and pharmacy interventions in community practice. International Journal of Pharmacy Practice, 7, 40 50. (Pubitemid 29219290)
3. Paulino EI, Bouvy ML, Gastelurrutia MA, Guerreiro M, Buurma H (2004) Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharmacy World and Science, 26, 353 360.
4. Hämmerlein A, Grise N, Schulz M (2007) Survey of drug-related problems identified by community pharmacies. Annals of Pharmacotherapy, 41, 1825 1832. E-pub 2007 October 9. doi.
5. Rao D, Gilbert A, Strand LM, Cipolle RJ (2007) Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia. Pharmacy World and Science, 29, 647 654.
6. Johnson JA, Bootman JL (1995) Drug-related morbidity and mortality: a cost-of-illness model. Archives of Internal Medicine, 155, 1949 1956.
7. Ernst FR, Grizzle AJ (2001) Drug-related morbidity and mortality: updating the cost-of-illness model. Journal of the American Pharmaceutical Association, 41, 192 199.
8. Bugnon O (2008) Pharmacy practice, present and future: what will be needed to close the gap between efficacy and effectiveness? (oral presentation).
9. van Mil JWF, Westerlund LOT, Hersberger KE, Schaefer MA (2004) Drug-related problem classification systems. Annals of Pharmacotherapy, 38, 859 867. E-pub 2004 March 30. doi.
10. van Mil F (ed 1999) Proceedings of the international working conference on outcomes measurements in pharmaceutical care.
11. Hepler CD, Strand LM (1990) Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy, 47, 533 543.
12. Winterstein AG, Sauer BC, Hepler CD, Poole C (2002) Preventable drug-related hospital admissions. Annals of Pharmacotherapy, 36, 1238 1248. doi.
13. Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: meta-analysis of prospective studies. Journal of the American Medical Association, 279, 1200 1205.
14. Beijer HJM, De Blaey CJ (2002) Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies. Pharmacy World and Science, 24, 46 54.
15. Mjörndal T, Danell Boman M, Hägg S, Bäckström M, Wiholm B-E, Wahlin A, Dahlqvist R (2002) Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiology and Drug Safety, 11, 65 72.
16. von Euler M, Eliasson E, Ohlen G, Bergman U (2006) Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiololgy and Drug Safety, 15, 178 184.
17. Fryckstedt J, Asker-Hagelberg C (2008) Läkemedelsrelaterade problem vanliga på medicinakuten. Swedish Läkartidningen, 105, 894 898.
18. Krähenbül-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krähenbühl S (2007) Drug related problems in hospitals - a review of the recent literature. Drug Safety, 30, 379 407.
19. Sorensen L, Stokes JA, Purdie DM, Woodward M, Roberts MS (2005) Medication management at home: medication-related risk factors associated with poor health outcomes. Age and Ageing, 34, 626 632.
20. Guignard AP, Couray-Targe S, Colin C, Chamba G (2003) Economic impact of pharmacists' interventions with nonsteroidal anti-inflammatory drugs. Annals of Pharmacotherapy, 37, 332 338. E-pub 2003 January 17. doi.
21. Scullin C, Scott MG, Hogg A, McElnay JC (2007) An innovative approach to integrated medicines management. Journal of Evaluation in Clinical Practice, 13, 781 788.
22. Westerlund T, Marklund B (2008) Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. Journal of Clinical Pharmacy and Therapeutics, 34, 319 327. E-pub 2008 December 22. doi.
23. Strand LM, Cipolle RJ, Morley PC, Frakes MJ (2004) The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience. Current Pharmaceutical Design, 10, 3987 4001.
24. Blakey SA, Hixson-Wallace JA (2000) Clinical and economic effects of pharmacy services in geriatric ambulatory clinic. Pharmacotherapy, 20, 1198 1203.
25. Koshman SL, Charrois TL, Simpson SH, McAlister FA, Tsuyuki RT (2008) Pharmacist care of patients with heart failure. A systematic review of randomized trials. Archives of Internal Medicine, 168, 687 694.
26. Benrimoj SI, Langford JH, Berry G et al. (2000) Economic impact of increased clinical intervention rates in community pharmacy. A randomized trial of the effect of education and a professional allowance. Pharmacoeconomics, 18, 459 468.
27. Barber N (2001) Pharmaceutical care and medicines management - is there a difference? Pharmacy World and Science, 23, 210 211.
28. American Pharmacists Association; National Association of Chain Drug Stores Foundation (2008) Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). Journal of the American Pharmacists Association, 48, 341 353.
29. Roberts AS, Benrimoj SI, Chen TF, Williams KA, Aslani P (2008) Practice change in community pharmacy: quantification of facilitators. Annals of Pharmacotherapy, 42, 861 868. E-pub 2008 May 13. doi.
30. Krähenbühl J-M, Kremer B, Guignard B, Bugnon O (2008) Practical evaluation of the drug-related problem management process in Swiss community pharmacies. Pharmacy World and Science, 30, 777 786. E-pub 2008 April 6. doi.
31. Westerlund T, Allebeck P, Marklund B, Andersson I-L, Bråstad J-O, Sjöblom M (2003) Evaluation of a model for counseling patients with dyspepsia in Swedish community pharmacies. American Journal of Health-System Pharmacy, 60, 1336 1341.
32. Westerlund LOT, Björk HT (2006) Pharmaceutical care in community pharmacies: practice and research in Sweden. Annals of Pharmacotherapy, 40, 1162 1169. E-pub 2006 May 30. doi.
33. Nilsson JLG, Andersson å, Kälvemark S, Lieberman-Ram H, Ullenius B, Wendel A, åberg å (2000) Surveys of drug-related therapy problems of patients using medicines for allergy, asthma and pain. International Journal of Pharmacy Practice, 8, 198 203.
34. Bell JS, Whitehead P, Aslani P, McLachlan AJ, Chen TF (2006) Drug-related problems in the community setting. Pharmacists' findings and recommendations for people with mental illnesses. Clinical Drug Investigation, 26, 415 423.
35. Haugbølle LS, Sørensen EW (2006) Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma - interviewing patients at home. Pharmacy World and Science, 28, 239 247. E-pub 2006 October 26. doi.
36. Westerlund T, Almarsdóttir AB, Melander A (1999) Factors influencing the detection rate of drug-related problems in community pharmacy. Pharmacy World and Science, 21, 245 250. (Pubitemid 30041074)
37. Herborg H, Frøkjaer B, Søndergaard B, Vilstrup Thomsen D, Glintborg Bohmann D (2001) Danish Forbedret selvmedicinering og egenomsorg. Et udviklings- og pilotprojekt for en kontrolleret undersøgelse.
38. de Almeida Neto AC, Kelly FS (2001) Communication and behaviour modification techniques and use of protocols (oral presentation).
39. Bowling A (1998) Research methods in health. Investigating health and health services.
40. Charrois TL, Newman SC, Senthilselvan A, Tsuyuki RT (2006) Improving asthma control in the rural setting: the BREATHE (better respiratory education and asthma treatment in hinton and edson) study. Canadian Pharmaceutical Journal, 139, 44 50.
41. Odedina FT, Segal R, Hepler CD, Lipowski E, Kimberlin C (1996) Changing pharmacists' practice pattern: implementation of pharmaceutical care factors. Journal of Social and Administrative Pharmacy, 13, 74 88.
42. Willison DJ, Muzzin LJ (1995) Workload, data gathering, and quality of community pharmacists' advice. Medical Care, 33, 29 40.
43. Westerlund LOT, Handl WHA, Marklund BRG, Allebeck P (2003) Pharmacy practitioners' views on computerized documentation of drug-related problems. Annals of Pharmacotherapy, 37, 354 360. E-pub 2003 February 9. doi.
44. Montgomery AT, Kälvemark Sporrong S, Tully MP, Kettis Lindblad å (2008) Follow-up of patients receiving a pharmaceutical care service in Sweden. Journal of Clinical Pharmacy and Therapeutics, 33, 653 662.
45. Chen TF, de Almeida Neto AC (2007) Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review. Pharmacy World and Science, 29, 574 576. E-pub 2007 May 4.
46. Dolovich L, Gugnon A, McAiney CA, Sparrow L, Burns S (2008) Initial pharmacist experience with the Ontario-based MedsCheck program. Canadian Pharmaceutical Journal, 141, 339 345.
47. Management Committee (2008 Moving forward: Pharmacy human resources for the future. Innovative pharmacy practices: analysis and overview, Vol. 1.
48. Cipolle CL, Cipolle RJ, Strand LM (2006) Consistent standards in medication use: the need to care for patients from research to practice. Journal of the American Pharmacists Association, 46, 205 212.
49. Schaefer M (2002) Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharmacy World and Science, 24, 120 127.
50. Allenet B, Bedouch P, Rose F-X et al. (2006) Validation of an instrument for the documentation of clinical pharmacsts' interventions. Pharmacy World and Science, 28, 181 188.